586 related articles for article (PubMed ID: 6609824)
1. Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity.
Liew FY; Russell SM; Appleyard G; Brand CM; Beale J
Eur J Immunol; 1984 Apr; 14(4):350-6. PubMed ID: 6609824
[TBL] [Abstract][Full Text] [Related]
2. Cross-protection against influenza A virus infection by passively transferred respiratory tract IgA antibodies to different hemagglutinin molecules.
Tamura S; Funato H; Hirabayashi Y; Suzuki Y; Nagamine T; Aizawa C; Kurata T
Eur J Immunol; 1991 Jun; 21(6):1337-44. PubMed ID: 1646112
[TBL] [Abstract][Full Text] [Related]
3. Protection and recovery in influenza virus-infected mice immunosuppressed with anti-IgM.
Kris RM; Asofsky R; Evans CB; Small PA
J Immunol; 1985 Feb; 134(2):1230-5. PubMed ID: 2981265
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of heterosubtypic immunity to lethal influenza A virus infection in fully immunocompetent, T cell-depleted, beta2-microglobulin-deficient, and J chain-deficient mice.
Epstein SL; Lo CY; Misplon JA; Lawson CM; Hendrickson BA; Max EE; Subbarao K
J Immunol; 1997 Feb; 158(3):1222-30. PubMed ID: 9013963
[TBL] [Abstract][Full Text] [Related]
5. Assessment of resistance to influenza virus infection in animal models.
Potter CW; McLaren C; Jennings R
Dev Biol Stand; 1975; 28():307-18. PubMed ID: 1126574
[TBL] [Abstract][Full Text] [Related]
6. TH cells primed during influenza virus infection provide help for qualitatively distinct antibody responses to subsequent immunization.
Marshall D; Sealy R; Sangster M; Coleclough C
J Immunol; 1999 Nov; 163(9):4673-82. PubMed ID: 10528164
[TBL] [Abstract][Full Text] [Related]
7. Mice can recover from pulmonary influenza virus infection in the absence of class I-restricted cytotoxic T cells.
Scherle PA; Palladino G; Gerhard W
J Immunol; 1992 Jan; 148(1):212-7. PubMed ID: 1530795
[TBL] [Abstract][Full Text] [Related]
8. Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection.
Ichinohe T; Watanabe I; Ito S; Fujii H; Moriyama M; Tamura S; Takahashi H; Sawa H; Chiba J; Kurata T; Sata T; Hasegawa H
J Virol; 2005 Mar; 79(5):2910-9. PubMed ID: 15709010
[TBL] [Abstract][Full Text] [Related]
9. Defense mechanisms against influenza virus infection in the respiratory tract mucosa.
Tamura S; Kurata T
Jpn J Infect Dis; 2004 Dec; 57(6):236-47. PubMed ID: 15623947
[TBL] [Abstract][Full Text] [Related]
10. Protection against lethal influenza virus encephalitis by intranasally primed CD8+ memory T cells.
Stevenson PG; Hawke S; Bangham CR
J Immunol; 1996 Oct; 157(7):3065-73. PubMed ID: 8816416
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of broad cross-protection provided by influenza virus infection and their application to vaccines.
Tamura S; Tanimoto T; Kurata T
Jpn J Infect Dis; 2005 Aug; 58(4):195-207. PubMed ID: 16116250
[TBL] [Abstract][Full Text] [Related]
12. Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function.
Sambhara S; Kurichh A; Miranda R; Tumpey T; Rowe T; Renshaw M; Arpino R; Tamane A; Kandil A; James O; Underdown B; Klein M; Katz J; Burt D
Cell Immunol; 2001 Aug; 211(2):143-53. PubMed ID: 11591118
[TBL] [Abstract][Full Text] [Related]
13. Superior cross-protective effect of nasal vaccination to subcutaneous inoculation with influenza hemagglutinin vaccine.
Tamura SI; Asanuma H; Ito Y; Hirabayashi Y; Suzuki Y; Nagamine T; Aizawa C; Kurata T; Oya A
Eur J Immunol; 1992 Feb; 22(2):477-81. PubMed ID: 1537382
[TBL] [Abstract][Full Text] [Related]
14. Do L3T4+ T cells act as effector cells in protection against influenza virus infection.
Lightman S; Cobbold S; Waldmann H; Askonas BA
Immunology; 1987 Sep; 62(1):139-44. PubMed ID: 2820868
[TBL] [Abstract][Full Text] [Related]
15. Heterotypic protective immune reactions in mice infected with distinct serotypes of human influenza virus.
Floc'h F; Werner GH
Ann Microbiol (Paris); 1978; 129(4):509-24. PubMed ID: 308787
[TBL] [Abstract][Full Text] [Related]
16. Dose dependence of CTL precursor frequency induced by a DNA vaccine and correlation with protective immunity against influenza virus challenge.
Fu TM; Guan L; Friedman A; Schofield TL; Ulmer JB; Liu MA; Donnelly JJ
J Immunol; 1999 Apr; 162(7):4163-70. PubMed ID: 10201942
[TBL] [Abstract][Full Text] [Related]
17. Defense mechanisms against primary influenza virus infection in mice. I. The roles of interferon and neutralizing antibodies and thymus dependence of interferon and antibody production.
Iwasaki T; Nozima T
J Immunol; 1977 Jan; 118(1):256-63. PubMed ID: 401512
[TBL] [Abstract][Full Text] [Related]
18. Antibodies and CD4(+) T-cells mediate cross-protection against H5N1 influenza virus infection in mice after vaccination with a low pathogenic H5N2 strain.
Droebner K; Haasbach E; Fuchs C; Weinzierl AO; Stevanovic S; Büttner M; Planz O
Vaccine; 2008 Dec; 26(52):6965-74. PubMed ID: 18848593
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis of and immunity to avian influenza A H5 viruses.
Katz JM; Lu X; Frace AM; Morken T; Zaki SR; Tumpey TM
Biomed Pharmacother; 2000 May; 54(4):178-87. PubMed ID: 10872716
[TBL] [Abstract][Full Text] [Related]
20. Maternal-infant transfer of influenza-specific immunity in the mouse.
Reuman PD; Paganini CM; Ayoub EM; Small PA
J Immunol; 1983 Feb; 130(2):932-6. PubMed ID: 6848601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
